Clinical Trial Update: Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bicalutamide with or without everolimus in recurrent or metastatic prostate cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Everolimus (everolimus)
• bicalutamide (bicalutamide)

Snippet

Sponsor: University of California, Davis | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-06-01